Related Experiment Video
Updated: May 4, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
4.8K
Informatics applied to pharmacovigilance: Future perspectives.
Michele Menniti1, Annamaria Menniti1, Marinella Patanè1
1Department of Science of Health, School of Medicine, University of Catanzaro and Pharmacovigilance Centre, Calabria Region, University Hospital Mater Domini, Catanzaro, Italy.
Journal of Pharmacology & Pharmacotherapeutics
|December 19, 2013
Summary
Improving spontaneous adverse drug reaction (ADR) reporting is crucial for drug safety. Enhancing the online platform and professional support can streamline ADR data collection and accessibility for better pharmacovigilance.
Area of Science:
- Pharmacovigilance and Drug Safety
- Public Health
- Health Informatics
Background:
- Spontaneous adverse drug reaction (ADR) reporting is vital for drug safety monitoring.
- Current reporting relies on manual processes, leading to inefficiencies and underreporting.
- The national ADR database lacks accessibility for reporters and healthcare professionals.
Purpose of the Study:
- To highlight the limitations of the current ADR reporting system.
- To propose improvements for a more efficient and accessible pharmacovigilance system.
- To advocate for enhanced data management and professional support in ADR reporting.
Main Methods:
- Analysis of the current manual ADR reporting workflow.
- Identification of barriers to reporting and data accessibility.
- Proposal for an improved online reporting platform and specialized personnel.
Main Results:
- The existing system is cumbersome, causing underreporting due to data issues and complexity.
- Limited access to the national database restricts transparency and data utilization.
- A need exists for qualified pharmacovigilance professionals to support reporting.
Conclusions:
- Enhancing the online platform for ADR upload can improve data inspection and accessibility.
- Granting access to reporters and healthcare professionals would increase data utility.
- Implementing specialized pharmacovigilance roles is essential for better citizen and reporter support.
More Related Videos
Related Concept Videos
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:20Measurement of Bioavailability: Pharmacodynamic Methods
1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
01:29Pharmacogenetics and Pharmacogenomics: Overview
253
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
253
01:12Analysis of Population Pharmacokinetic Data
996
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
996